Kevin C. Gatter
About
In The Last Decade
Kevin C. Gatter
310 papers receiving 26.1k citations
Hit Papers
Peers
Comparison fields: 5 of 157
- Molecular Biology 12.7k
- Cancer Research 8.4k
- Oncology 8.2k
- Pathology and Forensic Medicine 4.7k
- Immunology 3.6k
Countries citing papers authored by Kevin C. Gatter
This map shows the geographic impact of Kevin C. Gatter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin C. Gatter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin C. Gatter more than expected).
Fields of papers citing papers by Kevin C. Gatter
This network shows the impact of papers produced by Kevin C. Gatter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin C. Gatter. The network helps show where Kevin C. Gatter may publish in the future.
Co-authorship network of co-authors of Kevin C. Gatter
This figure shows the co-authorship network connecting the top 25 collaborators of Kevin C. Gatter. A scholar is included among the top collaborators of Kevin C. Gatter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin C. Gatter. Kevin C. Gatter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 14 | |
| 2 | 63 | |
| 3 | 12 | |
| 4 | 188 | |
| 5 | 143 | |
| 6 | Hypoxia and activated VEGF/receptor pathway in multiple myeloma. | 62 |
| 7 | 165 | |
| 8 | 203 | |
| 9 | 64 | |
| 10 | Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival. | 263 |
| 11 | Relation of hypoxia-inducible factor-2 alpha (HIF-2 alpha) expression in tumor-infiltrative macrophages to tumor angiogenesis and the oxidative thymidine phosphorylase pathway in Human breast cancer. | 177 |
| 12 | Hypoxia-inducible factors HIF-1alpha and HIF-2alpha in head and neck cancer: relationship to tumor biology and treatment outcome in surgically resected patients. | 252 |
| 13 | 407 | |
| 14 | The Expression and Distribution of the Hypoxia-Inducible Factors HIF-1α and HIF-2α in Normal Human Tissues, Cancers, and Tumor-Associated Macrophages breakdown → | 1078 |
| 15 | Induction of Endothelial PAS Domain Protein-1 by Hypoxia: Characterization and Comparison With Hypoxia-Inducible Factor-1α breakdown → | 539 |
| 16 | 12 | |
| 17 | 7 | |
| 18 | 12 | |
| 19 | 374 | |
| 20 | 71 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.